Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage

American Journal of Physiology - Endocrinology and Metabolism

Volumn 273, Issue 1 36-1, 1997, Pages

  Dawson, Ralph ^a   Pelleymounter, Mary Ann ^b   Millard, William J ^a   Liu, Steve ^a   Eppler, Baerbel ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b AMGEN INC   (United States)

Author keywords

Feeding; Hypothalamus; Leptin receptor; Ob protein; Obesity

Indexed keywords

GLUTAMATE SODIUM; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BINDING SITE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; GROWTH HORMONE RELEASE; HYPERPHAGIA; HYPOTHALAMUS; NONHUMAN; OBESITY; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT;

EID: 0030759490     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.273.1.e202     Document Type: Article

References (31)

1. Baker, M., M. Cullen, W. Karbon, and M. Pelleymounter. Goldthioglucose lesions partially block leptin's effects in oblob mice (Abstract). Soc. Neurosci. Abstr. 22: 846, 1996.
2. Campfield, L. A., F. J. Smith, Y. Guisez, R. Devos, and P. Burn. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
3. Dawson, R. Developmental and sex-specific effects of low dose neonatal monosodium glutamate (MSG) administration on medio-basal hypothalamic chemistry. Neuroendocrinology 42: 158-166, 1986.
4. Dawson, R., and Z. Annau. A behavioral assessment of arcuate nucleus damage after a single injection of monosodium glutamate. Neurobehav. Toxicol. Teratol. 5: 399-406, 1983.
5. Dawson, R., J. W. Simpkins, and D. R. Wallace. Age and dose-dependent effects of neonatal monosodium glutamate administration to female rats. Neurotoxicol. Teratol. 11: 331-337, 1989.
6. Dawson, R., D. R. Wallace, and S. M. Gabriel. A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). Pharmacol. Biochem. Behav. 32: 391-398, 1989.
7. Devos, R., J. G. Richards, L. A. Campfield, L. A. Tartaglia, Y. Guisez, J. van der Heyden, J. Travernier, G. Plaetinck, and P. Burn. OB protein binds specifically to the choroid plexus of mice and rats. Proc. Natl. Acad. Sci. USA 93: 5668-5673, 1996.
8. Erickson, J. C., K. E. Clegg, and R. D. Palmiter. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-418, 1996.
9. Frederich, R. C., B. Lollmann, A. Hamann, A. Napolitano-Rosen, B. B. Kahn, B. B. Lowell, and J. S. Flier. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96: 1658-1663, 1995.
10. Ghilardi, N., S. Ziegler, A. Wiestner, R. Stoffel, M. H. Heim, and R. C. Skoda. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93: 6231-6235, 1996.
11. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley, and J. M. Friedman. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
12. Lee, G.-H., R. Proenca, J. M. Montez, K. M. Carroll, J. G. Darvishzadeh, J. I. Lee, and J. M. Friedman. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635, 1996.
13. Lorden, J. F., R. Dawson, and M. Callahan. Effects of goldthioglucose lesions on central catecholamine levels in the mouse. Pharmacol. Biochem. Behav. 10: 165-169, 1979.
14. Maffei, M., H. Fei, G.-H. Lee, C. Dani, P. Leroy, Y. Zhang, R. Proenca, R. Negrel, G. Ailhaud, and J. M. Friedman. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc. Natl. Acad. Sci. USA 92: 6957-6960, 1995.
15. Malick, K. F., and W. S. Young. Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology 137: 1497-1500, 1996.
16. Meister, B., S. Ceccatelli, T. Hokfelt, N.-E. Anden, and E. Theodorsson. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp. Brain Res. 76: 343-368, 1989.
17. Mercer, J. G., N. Hoggard, L. M. Williams, C. B. Lawrence, L. T. Hannah, and P. Trayhurn. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387: 113-116, 1996.
18. Mercer, J. G., N. Hoggard, L. M. Williams, C. B. Lawrence, L. T. Hannah, P. J. Morgan, and P. Trayhurn. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J. Neuroendocrinol. 8: 733-735, 1996.
19. Millard, W. J., J. B. Martin, Jr., J. Audet, S. M. Sager, and J. B. Martin. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110: 540-550, 1982.
20. Nemeroff, C. B., M. A. Lipton, and J. S. Kizer. Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. Dev. Neurosci. 1: 102-109, 1978.
21. Olney, J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721, 1969.
22. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
23. Schwartz, M. W., D. G. Baskin, T. R. Bukowski, J. L. Kuijper, D. Foster, G. Lasser, D. E. Prunkard, D. Porte, S. C. Woods, R. J. Seely, and D. S. Weigle. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535, 1996.
24. Schwartz, M. W., R. J. Seeley, L. A. Campfield, P. Burn, and D. G. Baskin. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98: 1101-1106, 1996.
25. Seress, L. Divergent effects of acute and chronic monosodium L-glutamate treatment on the anterior and posterior parts of the arcuate nucleus. Neuroscience 7: 2207-2216, 1982.
26. Stephens, T. W., M. Basinski, P. K. Bristow, J. M. Bue-Valleskey, S. G. Burgett, L. Craft, J. Hale, J. Hoffman, H. M. Hsiung, A. Kriauciunas, W. MacKellar, P. R. Rosteck, B. Schoner, D. Smith, F. C. Tinsley, X.-Y. Zhang, and M. Heiman. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532, 1995.
27. Tartaglia, L. A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G. J. Richards, L. A. Campfield, F. T. Clark, J. Deeds, C. Muir, S. Sanker, A. Moriarty, K. J. Moore, J. S. Smutko, G. G. Mays, E. A. Woolf, C. A. Monroe, and R. I. Tepper. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271, 1995.
28. Wang, M.-Y., Y. T. Zhou, C. B. Newgard, and R. H. Unger. A novel leptin receptor isoform in rat. FEBS Lett. 392: 87-90, 1996.
29. Weigle, D. S., T. R. Bukowski, D. C. Foster, S. Holderman, J. M. Kramer, G. Lasser, C. E. Lofton-Day, D. E. Prunkard, C. Raymond, and J. Kuijper. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96: 2065-2070, 1995.
30. Yeh, J. K., J. F. Aloia, M. Chen, N. Ling, H.-C. Koo, and W. J. Millard. Effect of growth hormone administration and treadmill exercise on serum and skeletal muscle IGF-I in rats. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E129-E135, 1994.
31. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994.